When was Biolinq's last funding round?

Biolinq's most recent recorded round was Later Stage VC in Mar 2025, raising $90.0M.

PrivateMarketView

How much has Biolinq raised?

$312.8Macross 8 recorded rounds · Mar 2019 – Mar 2025

Most recently, Biolinq raised $90.0M in its Later Stage VC (Mar 2025).

Free account

More of Biolinq with a free account

No card required

Membership and data by Private Market View

8 rounds

Mar 2025Later Stage VC$90.0MSEC filing▮

45 investors participated

Dec 2023Debt$59.1MSEC filing▮

43 investors participated

Sep 2021Later Stage VC$77.9MSEC filing▮

62 investors participated

Mar 2021Debt$5.2MSEC filing▮

21 investors participated

Mar 2020Debt$3.6MSEC filing▮

17 investors participated

Mar 2019Seed Round$3.0MSEC filing▮

9 investors participated

+ 2 earlier rounds · a free account shows the full history

Biolinq has raised $313 million across 8 recorded rounds since 2016. The largest was a $90 million later-stage round in Mar 2025.

Biolinq has filed 12 Form Ds with the SEC since 2016, most recently in Mar 2025 ($90 million sold to 45 investors).

36 investors are on record for Biolinq, including MedTech Innovator, National Institutes of Health, CONNECT(San Diego) and Pegasus Tech Ventures. The later-stage round in Mar 2025 drew 45 investors.

For fundraisers

Raising for a company like Biolinq?

36 investors have backed Biolinq.

How much has Biolinq raised?: Biolinq has raised $312.8M in total across 8 recorded funding rounds.
When was Biolinq's last funding round?: Biolinq's most recent recorded round was Later Stage VC in Mar 2025, raising $90.0M.